<DOC>
	<DOC>NCT02274428</DOC>
	<brief_summary>Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical cord blood derived mesenchymal stem cells) in the premature infants with intraventricular hemorrhage (IVH, grade 3-4)</brief_summary>
	<brief_title>Phase 1 Clinical Trial of PNEUMOSTEMÂ® Treatment in Premature Infants With Intraventricular Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<criteria>2334w IVH grade 34, confirmed with brain ultrasonogram within 7 days after IVH diagnosis severe congenital anomaly intrauterine intracranial bleeding intracranial infection severe congenital infection active and uncontrolled infection, CRP&gt;10mg/dl Platelet count &lt;50,000/ml severe metabolic acidosis (PH&lt;7.1, BE&lt;20)</criteria>
	<gender>All</gender>
	<minimum_age>23 Weeks</minimum_age>
	<maximum_age>34 Weeks</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>intraventricular hemorrhage</keyword>
</DOC>